Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

1.

Association of metabolic syndrome with sensory gating deficits in patients with chronic schizophrenia.

Micoulaud-Franchi JA, Faugere M, Boyer L, Cermolacce M, Richieri R, Faget C, Philip P, Vion-Dury J, Lancon C.

Psychoneuroendocrinology. 2015 Jul;57:125-33. doi: 10.1016/j.psyneuen.2015.04.005. Epub 2015 Apr 15.

PMID:
25917886
2.

Elevated C-reactive protein is associated with sensory gating deficit in schizophrenia.

Micoulaud-Franchi JA, Faugere M, Boyer L, Fond G, Richieri R, Faget C, Cermolacce M, Philip P, Vion-Dury J, Lancon C.

Schizophr Res. 2015 Jun;165(1):94-6. doi: 10.1016/j.schres.2015.03.018. Epub 2015 Apr 10.

PMID:
25864954
3.

Sensory gating in adult with attention-deficit/hyperactivity disorder: Event-evoked potential and perceptual experience reports comparisons with schizophrenia.

Micoulaud-Franchi JA, Vaillant F, Lopez R, Peri P, Baillif A, Brandejsky L, Steffen ML, Boyer L, Richieri R, Cermolacce M, Bioulac S, Aramaki M, Philip P, Lancon C, Vion-Dury J.

Biol Psychol. 2015 Apr;107:16-23. doi: 10.1016/j.biopsycho.2015.03.002. Epub 2015 Mar 9.

PMID:
25766264
4.

Effects of clozapine on perceptual abnormalities and sensory gating: a preliminary cross-sectional study in schizophrenia.

Micoulaud-Franchi JA, Aramaki M, Geoffroy PA, Richieri R, Cermolacce M, Faget C, Ystad S, Kronland-Martinet R, Lancon C, Vion-Dury J.

J Clin Psychopharmacol. 2015 Apr;35(2):184-7. doi: 10.1097/JCP.0000000000000270.

PMID:
25587694
5.

Determinants of brain SPECT perfusion and connectivity in treatment-resistant depression.

Richieri R, Boyer L, Faget-Agius C, Farisse J, Mundler O, Lançon C, Guedj E.

Psychiatry Res. 2015 Feb 28;231(2):134-40. doi: 10.1016/j.pscychresns.2014.11.013. Epub 2014 Dec 3.

PMID:
25561373
6.

Perceptually or conceptually driven recognition: on the specificities of the memory deficit in schizophrenia.

Guillaume F, Thomas E, Faget C, Richieri R, Lançon C.

Psychiatry Res. 2015 Feb 28;225(3):493-500. doi: 10.1016/j.psychres.2014.11.060. Epub 2014 Dec 8.

PMID:
25535008
7.

Risk factors for treatment resistance in unipolar depression: a systematic review.

Bennabi D, Aouizerate B, El-Hage W, Doumy O, Moliere F, Courtet P, Nieto I, Bellivier F, Bubrovsky M, Vaiva G, Holztmann J, Bougerol T, Richieri R, Lancon C, Camus V, Saba G, Haesbaert F, d'Amato T, Charpeaud T, Llorca PM, Leboyer M, Haffen E.

J Affect Disord. 2015 Jan 15;171:137-41. doi: 10.1016/j.jad.2014.09.020. Epub 2014 Oct 8. Review.

PMID:
25305428
8.

Validation of the French sensory gating inventory: a confirmatory factor analysis.

Micoulaud-Franchi JA, Hetrick WP, Boyer L, Bolbecker A, Aramaki M, Ystad S, Richieri R, El-Kaim A, Faget C, Faugere M, Cermolacce M, Kronland-Martinet R, Lancon C, Vion-Dury J.

Psychiatry Res. 2014 Dec 30;220(3):1106-12. doi: 10.1016/j.psychres.2014.08.025. Epub 2014 Sep 3.

PMID:
25223255
9.

Neurophysiological correlates of metabolic syndrome and cognitive impairment in schizophrenia: a structural equation modeling approach.

Boyer L, Testart J, Michel P, Richieri R, Faget-Agius C, Vanoye V, Auquier P, Lancon C, Guedj E.

Psychoneuroendocrinology. 2014 Dec;50:95-105. doi: 10.1016/j.psyneuen.2014.07.019. Epub 2014 Aug 10.

PMID:
25199983
10.

Ketamine administration in depressive disorders: a systematic review and meta-analysis.

Fond G, Loundou A, Rabu C, Macgregor A, Lançon C, Brittner M, Micoulaud-Franchi JA, Richieri R, Courtet P, Abbar M, Roger M, Leboyer M, Boyer L.

Psychopharmacology (Berl). 2014 Sep;231(18):3663-76. doi: 10.1007/s00213-014-3664-5. Epub 2014 Jul 20.

PMID:
25038867
11.

Do schizophrenia patients with low P50-suppression report more perceptual anomalies with the sensory gating inventory?

Micoulaud-Franchi JA, Hetrick WP, Aramaki M, Bolbecker A, Boyer L, Ystad S, Kronland-Martinet R, Richieri R, Faget C, Faugere M, El-Kaim A, Cermolacce M, Lancon C, Vion-Dury J.

Schizophr Res. 2014 Aug;157(1-3):157-62. doi: 10.1016/j.schres.2014.05.013. Epub 2014 Jun 2.

PMID:
24893905
12.

[Ketamine in acute and severe major depressive disorder].

Brittner M, Micoulaud-Franchi JA, Richieri R, Boyer L, Adida M, Lancon C, Fond G.

Presse Med. 2014 May;43(5):492-500. doi: 10.1016/j.lpm.2013.11.013. Epub 2014 Mar 12. Review. French.

PMID:
24630265
13.

Resistant bipolar depressive disorder: case analysis of adjunctive transcranial magnetic stimulation efficiency in medical comorbid conditions.

Zendjidjian XY, Lodovighi MA, Richieri R, Guedj E, Boyer L, Dassa D, Lançon C.

Bipolar Disord. 2014 Mar;16(2):211-3. doi: 10.1111/bdi.12170. Epub 2013 Dec 18. No abstract available.

PMID:
24350675
14.

Structural and functional reorganization of working memory system during the first decade in schizophrenia. A cross-sectional study.

Faget-Agius C, Boyer L, Lançon C, Richieri R, Fassio E, Soulier E, Chanoine V, Auquier P, Ranjeva JP, Guye M.

Schizophr Res. 2013 Dec;151(1-3):48-60. doi: 10.1016/j.schres.2013.10.023. Epub 2013 Nov 11.

PMID:
24230490
15.

Quality of life and other outcome measures in caregivers of patients with schizophrenia.

Testart J, Richieri R, Caqueo-Urízar A, Lancon C, Auquier P, Boyer L.

Expert Rev Pharmacoecon Outcomes Res. 2013 Oct;13(5):641-9. doi: 10.1586/14737167.2013.838022. Epub 2013 Oct 7. Review.

PMID:
24098967
16.

[Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].

Dumas R, Boyer L, Richieri R, Guedj E, Auquier P, Lançon C.

Encephale. 2014 Feb;40(1):74-80. doi: 10.1016/j.encep.2013.04.004. Epub 2013 Oct 1. French.

PMID:
24091070
17.

Association of metabolic syndrome and inflammation with neurocognition in patients with schizophrenia.

Boyer L, Richieri R, Dassa D, Boucekine M, Fernandez J, Vaillant F, Padovani R, Auquier P, Lancon C.

Psychiatry Res. 2013 Dec 15;210(2):381-6. doi: 10.1016/j.psychres.2013.06.020. Epub 2013 Jul 10.

PMID:
23850204
18.

[Interactive rTMS protocols in psychiatry].

Micoulaud-Franchi JA, Richieri R, Lancon C, Vion-Dury J.

Encephale. 2013 Dec;39(6):426-31. doi: 10.1016/j.encep.2013.04.009. Epub 2013 Jun 28. Review. French.

PMID:
23810752
19.

Maintenance transcranial magnetic stimulation reduces depression relapse: a propensity-adjusted analysis.

Richieri R, Guedj E, Michel P, Loundou A, Auquier P, Lançon C, Boyer L.

J Affect Disord. 2013 Oct;151(1):129-35. doi: 10.1016/j.jad.2013.05.062. Epub 2013 Jun 18.

PMID:
23790811
20.

Single-photon emission computed tomography findings in a patient with Fahr disease associated with a schizophrenia-like psychosis.

Boyer L, Guedj E, Richieri R, Vaillant F, Lancon C.

J Clin Psychiatry. 2013 May;74(5):e431-2. doi: 10.4088/JCP.12cr08345. No abstract available.

PMID:
23759462
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk